Making HPV vaccination available to girls everywhere

International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics
Austin M OberlinCarla J Chibwesha

Abstract

Cervical cancer is currently the fourth leading cause of cancer death among women worldwide, with most cases occurring in low- and middle-income countries. Safe, highly effective vaccines against HPV have been on the market since 2006, yet only 6% of girls worldwide have received this life-saving cancer prevention intervention. International organizations, including PATH, Gavi, and the pharmaceutical companies Merck and GlaxoSmithKline, have provided support to eligible low- and middle-income countries to implement national HPV vaccination programs. Still, glaring disparities in the availability of national HPV vaccination programs and the coverage of the primary target population between the global north and south persist. We illustrate worldwide HPV vaccine implementation and coverage using an online data visualization, which is publicly available and can be used to gain unique insights. We also present three emerging solutions to transform future HPV vaccine delivery in low- and middle-income countries: low-cost generics, single-dose vaccination, and co-administration with other adolescent vaccines. By rapidly expanding access to HPV vaccination to girls everywhere, vaccine-type HPV infections can be virtually eliminated. At...Continue Reading

References

Jun 25, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Myron J LevinUNKNOWN IMPAACT P1047 Protocol Team
Jul 14, 2010·Nature Biotechnology·Swathi PadmanabhanSubhashini Chandrasekharan
Nov 16, 2011·Bulletin of the World Health Organization·D Scott LaMontagneAisha O Jumaan
Aug 16, 2012·Bulletin of the World Health Organization·Agnes BinagwahoFidele Ngabo
Oct 30, 2012·Journal of the National Cancer Institute·Nicolas Van de VeldeMarc Brisson
Jan 15, 2014·Vaccine·Alinea S NoronhaEileen F Dunne
Feb 19, 2015·The New England Journal of Medicine·Elmar A JouraUNKNOWN Broad Spectrum HPV Vaccine Study
Jun 14, 2015·The Lancet Oncology·Aimée R KreimerUNKNOWN GSK Vaccines Clinical Study Support Group
Jul 1, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Beatriz SerranoLaia Alemany
Sep 2, 2015·Nature Reviews. Clinical Oncology·F Xavier BoschJack Cuzick
Dec 15, 2015·The Lancet Oncology·Rengaswamy SankaranarayananUNKNOWN Indian HPV Vaccine Study Group
Aug 26, 2016·MMWR. Morbidity and Mortality Weekly Report·Sarah Reagan-SteinerJames A Singleton
Oct 25, 2016·Vaccine·Chaevia ClendinenDonald W Light
Jun 10, 2017·Vaccine·UNKNOWN World Health Organization. Electronic address: sageexecsec@who.int
Jul 12, 2017·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·D Scott LaMontagneCathy Ndiaye
Sep 28, 2017·Journal of the National Cancer Institute·Mahboobeh SafaeianUNKNOWN Costa Rica HPV Vaccine Trial (CVT) Group

❮ Previous
Next ❯

Citations

Jan 25, 2020·The Cochrane Database of Systematic Reviews·Leila H AbdullahiCharles S Wiysonge
Oct 23, 2019·JAMA : the Journal of the American Medical Association·Carla J Chibwesha, Jeffrey S A Stringer
Sep 3, 2019·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Michael GearyElizabeth Stringer
Jun 27, 2019·Cells·Patti OlusolaSantanu Dasgupta
Oct 21, 2020·JAMA : the Journal of the American Medical Association·Julia M LempPascal Geldsetzer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.